Document:

<PAGE>

                                                                     EXHIBIT 4.1

                  This Warrant was originally issued on November 25, 2002 and
                  such issuance was not registered under the Securities Act of
                  1933, as amended. The transfer of this Warrant and the
                  securities obtainable upon exercise hereof is subject to the
                  limitations and conditions on transfer specified in the Letter
                  Agreement, dated as of November 25, 2002 (as it may be amended
                  from time to time, the "LETTER AGREEMENT"), between the
                  Company, R.H. Donnelley Inc. and the Registered Holder (each
                  as defined herein), and the Company reserves the right to
                  refuse the transfer of any such securities until such
                  limitations have lapsed and conditions have been fulfilled,
                  with respect to such transfer. Upon written request, a copy of
                  the Letter Agreement shall be furnished by the Company to the
                  holder hereof without charge.

                           R.H. DONNELLEY CORPORATION

                             STOCK PURCHASE WARRANT
                             -----------------------

Date of Issuance:  November 25, 2002                       Certificate No. _____

                  FOR VALUE RECEIVED, R.H. Donnelley Corporation, a Delaware
corporation (the "COMPANY"), hereby grants to _______________________________ or
its registered assigns (the "REGISTERED HOLDER") the right to purchase from the
Company _________ shares of the Company's Common Stock at the Exercise Price.
This Warrant is one of several warrants (collectively, the "SERIES 1 WARRANTS")
issued by the Company to certain investors (the "INVESTORS") pursuant to the
letter agreement, dated as of November 25, 2002 (the "LETTER AGREEMENT").
Certain capitalized terms used herein are defined in SECTION 4 and capitalized
terms used in this Warrant but not defined herein shall have the meanings
ascribed thereto in the Letter Agreement. The amount and kind of securities
obtainable pursuant to the purchase rights granted hereunder and the purchase
price for such securities are subject to adjustment pursuant to the provisions
contained in this Warrant.

                  This Warrant is subject to the following provisions:

                  Section 1. EXERCISE OF WARRANT. (a) EXERCISE PERIOD. The
Registered Holder may exercise, in whole or in part (but not as to a fractional
share of Common Stock), the purchase rights represented by this Warrant at any
time and from time to time after the Date of Issuance to and including the fifth
anniversary of the earlier of (i) the issuance of warrants under the Purchase
Agreement or (ii) termination of the Purchase Agreement prior to the closing
thereunder (the "EXERCISE PERIOD").

                  (b) EXERCISE PROCEDURE. (i) This Warrant shall be deemed to
have been exercised when the Company has received all of the following items
(the "EXERCISE TIME"):

<PAGE>

                  (A) a completed Exercise Agreement, as defined in SECTION
         1(c), executed by the Person exercising all or part of the purchase
         rights represented by this Warrant (the "PURCHASER");

                  (B) this Warrant;

                  (C) if this Warrant is not registered in the name of the
         Purchaser, an Assignment or Assignments in the form set forth in
         EXHIBIT I evidencing the assignment of this Warrant to the Purchaser,
         in which case the Registered Holder shall have complied with the
         provisions set forth in SECTION 6; and

                  (D) either (1) a check payable to the Company in an amount
         equal to the product of the Exercise Price multiplied by the number of
         shares of Common Stock being purchased upon such exercise (the
         "AGGREGATE EXERCISE PRICE"), or (2) a written notice to the Company
         that the Purchaser is exercising the Warrant (or a portion thereof) by
         authorizing the Company to withhold from issuance a number of shares of
         Common Stock issuable upon such exercise of the Warrant that when
         multiplied by the Current Market Price of the Common Stock is equal to
         the Aggregate Exercise Price (which withheld shares shall no longer be
         issuable under this Warrant).

                  (ii) Certificates for shares of Common Stock purchased upon
exercise of this Warrant shall be delivered by the Company to the Purchaser
within five Business Days after the date on which the Exercise Time occurs.
Unless this Warrant has expired or all of the purchase rights represented hereby
have been exercised, the Company shall prepare a new Warrant, substantially
identical hereto, representing the purchase rights formerly represented by this
Warrant that have not expired or been exercised and shall within such
five-Business Day period deliver such new Warrant to the Person designated for
delivery in the Exercise Agreement.

                  (iii) The Common Stock issuable upon the exercise of this
Warrant shall be deemed to have been issued to the Purchaser at the Exercise
Time, and the Purchaser shall be deemed for all purposes to have become the
record holder of such Common Stock as of the Exercise Time.

                  (iv) The issuance of certificates for shares of Common Stock
upon exercise of this Warrant shall be made without charge to the Registered
Holder or the Purchaser for any issuance tax in respect thereof if issued to the
Registered Holder or other cost incurred by the Company in connection with such
exercise and the related issuance of shares of Common Stock. Each share of
Common Stock issuable upon exercise of this Warrant shall upon payment of the
Exercise Price therefor, be fully paid and nonassessable and free from all liens
and charges with respect to the issuance thereof.

                  (v) The Company shall not close its books against the transfer
of this Warrant or of any share of Common Stock issued or issuable upon the
exercise of this Warrant in any manner that interferes with the timely and
proper exercise of this Warrant.

                  (vi) Notwithstanding any other provision hereof, if an
exercise of any portion of this Warrant is to be made in connection with a
registered public offering or the sale of the Company, the exercise of any
portion of this Warrant may, at the election of the holder hereof,

                                       2
<PAGE>

be conditioned upon the consummation of the public offering or sale of the
Company in which case such exercise shall not be deemed to be effective until
the consummation of such transaction.

                  (vii) The Company shall at all times reserve and keep
available out of its authorized but unissued shares of Common Stock, solely for
the purpose of issuance upon the exercise of the Series 1 Warrants, such number
of shares of Common Stock issuable upon the exercise of all outstanding Series 1
Warrants. The Company shall take all such actions as may be necessary to assure
that all such shares of Common Stock may be so issued without violation of any
law or governmental regulation applicable to the Company or any requirements of
any domestic securities exchange upon which shares of Common Stock may be listed
(except for official notice of issuance that shall be immediately delivered by
the Company upon each such issuance). The Company shall not take any action that
would cause the number of authorized but unissued shares of Common Stock to be
less than the number of such shares required to be reserved hereunder for
issuance upon exercise of the Series 1 Warrants.

                  (c) EXERCISE AGREEMENT. Upon any exercise of this Warrant, the
Exercise Agreement shall be substantially in the form set forth in EXHIBIT II
(the "EXERCISE AGREEMENT"), except that if the shares of Common Stock are not to
be issued in the name of the Person in whose name this Warrant is registered,
the Exercise Agreement shall also state the name of the Person to whom the
certificates for the shares of Common Stock are to be issued, and if the number
of shares of Common Stock to be issued does not include all the shares of Common
Stock purchasable hereunder, it shall also state the name of the Person to whom
a new Warrant for the unexercised portion of the purchase rights hereunder is to
be delivered. Such Exercise Agreement shall be dated the actual date of
execution thereof.

                  (d) FRACTIONAL SHARES. If a fractional share of Common Stock
would be issuable upon exercise of the purchase rights represented by this
Warrant, the Company shall, unless prohibited by any agreement to which the
Company is a party, within five Business Days after the date on which the
Exercise Time occurs, deliver to the Purchaser a check payable to the Purchaser
in lieu of such fractional share in an amount equal to the difference between
Current Market Price of such fractional share as of the date on which the
Exercise Time occurs and the Exercise Price of such fractional share.

                  Section 2. ADJUSTMENT OF EXERCISE PRICE AND NUMBER OF SHARES.
In order to prevent dilution of the purchase rights granted under this Warrant,
the Exercise Price shall be subject to adjustment from time to time as provided
in this SECTION 2, and the number of shares of Common Stock obtainable upon
exercise of this Warrant shall be subject to adjustment from time to time as
provided in this SECTION 2.

                  (a) The Exercise Price shall be subject to adjustment as
follows:

                  (i) In case the Company shall at any time or from time to time
after the Date of Issuance (A) pay a dividend or make a distribution in shares
of Common Stock or Convertible Securities into Common Stock, (B) subdivide or
reclassify the outstanding shares of Common Stock into a greater number of
shares of Common Stock, (C) combine or reclassify the outstanding shares of
Common Stock into a smaller number of shares, or (D) otherwise issue by

                                       3
<PAGE>

reclassification of the shares of Common Stock any shares of capital stock of
the Company, then, and in each such case, the Exercise Price in effect
immediately prior to such action and the number of shares of Common Stock
obtainable upon exercise of this Warrant shall be proportionately adjusted so
that the holder of this Warrant shall be entitled to receive the number of
shares of Common Stock or other securities of the Company upon exercise of this
Warrant which such holder would have owned or have been entitled to receive
after the happening of any of the events described above had such Warrant been
exercised immediately prior to the happening of such event or the record date
therefor, whichever is earlier. An adjustment made pursuant to this SECTION
2(a)(i) shall become applicable (x) in the case of any such dividend or
distribution, immediately after the close of business on the record date for the
determination of holders of shares of Common Stock entitled to receive such
dividend or distribution and (y) in the case of any such subdivision,
reclassification or combination, at the close of business on the day upon which
such corporate action becomes effective. Such adjustment shall be made
successively.

                  (ii) In case the Company shall at any time or from time to
time after the Date of Issuance declare, order, pay or make a dividend or other
distribution (including without limitation any distribution of stock or other
securities, evidences of indebtedness, property or assets or rights or warrants
to subscribe for securities of the Company or any of its Subsidiaries) on its
Common Stock (other than (A) regular quarterly dividends payable in cash or (B)
dividends or distributions of shares of Common Stock referred to in SECTION
2(a)(i)) (any one of the foregoing other than the items specified in clause (A)
or (B) referred to as "SECURITIES OR ASSETS"), then and in each such case,
unless the Company elects to reserve shares or other units of such Securities or
Assets for distribution to the holders of the Series 1 Warrants upon the
exercise of such Series 1 Warrants so that any such holder exercising its Series
1 Warrants will receive upon such exercise, in addition to the shares of the
Common Stock to which such holder is entitled, the amount and kind of such
Securities or Assets which such holder would have received if such holder had,
immediately prior to the record date for the distribution of the Securities or
Assets, exercised its Warrant for Common Stock, the Exercise Price shall be
adjusted so that such Exercise Price shall equal the price determined by
multiplying the Exercise Price in effect immediately prior to the date of such
distribution by a fraction of which the numerator shall be the Current Market
Price of the Common Stock on such record date less the then fair market value
(as determined by the Board in good faith) of the portion of the capital stock
or assets or evidences of indebtedness so distributed or of such rights or
warrants applicable to one share of Common Stock, and of which the denominator
shall be the Current Market Price of the Common Stock on such record date;
PROVIDED, HOWEVER, that if the then fair market value (as so determined) of the
portion of the Securities or Assets so distributed applicable to one share of
Common Stock is equal to or greater than the Current Market Price of the Common
Stock on the record date mentioned above, in lieu of the foregoing adjustment,
adequate provision shall be made so that each holder of the Series 1 Warrants
shall have the right to receive the amount and kind of Securities or Assets
which such holder would have received had such holder exercised its Warrant
immediately prior to the record date for the distribution of the Securities or
Assets. Such adjustment shall become effective immediately after the record date
for the determination of shareholders entitled to receive such distribution.

                  (iii) In case the Company shall issue or sell any Common Stock
(or rights, Options, warrants or other Convertible Securities) (collectively,
"ADDITIONAL SHARES") at any

                                       4
<PAGE>

time after the date hereof until November 25, 2005 without consideration or for
a consideration per share (or having a exercise, exchange or exercise price per
share) (such per share amount, the "SALE PRICE") less than the greater of (A)
the Current Market Price per share of Common Stock on the date preceding the
earlier of the issuance or public announcement of the issuance of such
Additional Shares of Common Stock and (B) the Exercise Price as of the date of
such issuance of shares (or, in the case of Convertible Securities, less than
the greater of the Current Market Price or the Exercise Price, as the case may
be, as of the date of issuance of the rights, Options, warrants or other
securities in respect of which shares of Common Stock were issued) then, and in
each such case, the Exercise Price shall be reduced to an amount determined by
multiplying (A) the Exercise Price in effect on the day immediately prior to
such date by (B) a fraction, the numerator of which shall be the sum of (1) the
number of shares of Common Stock outstanding immediately prior to such sale or
issuance multiplied by the greater of (a) the then applicable Exercise Price per
share and (b) the Current Market Price per share of Common Stock on the date
preceding the earlier of the issuance or public announcement of the issuance of
such Additional Shares of Common Stock (the greater of (a) and (b) above
hereinafter referred to as the "ADJUSTMENT PRICE") and (2) the aggregate
consideration receivable by the Company for the total number of shares of Common
Stock so issued (or into or for which the rights, Options, warrants or other
securities are convertible, exercisable or exchangeable), and the denominator of
which shall equal to the product of (I) the sum of (x) the total number of
shares of Common Stock outstanding immediately prior to such sale or issue and
(y) the number of additional shares of Common Stock issued (or into or for which
the rights, Options, warrants or other securities may be converted, exercised or
exchanged), multiplied by (II) the Adjustment Price. In case any portion of the
consideration to be received by the Company shall be in a form other than cash,
the fair market value of such noncash consideration shall be utilized in the
foregoing computation. Such fair market value shall be determined in good faith
by the Board of Directors. Upon each such adjustment of the Exercise Price
hereunder, the number of Shares of Common Stock acquirable upon exercise of this
Warrant shall be adjusted to the number of shares determined by multiplying the
Exercise Price in effect immediately prior to such adjustment by the number of
shares of Common Stock acquirable upon exercise of this Warrant immediately
prior to such adjustment and dividing the product thereof by the Exercise Price
resulting from such adjustment. An adjustment made pursuant to this subsection
(iii) shall be made on the next Business Day following the date on which any
such issuance is made and shall be effective retroactively to the close of
business on the date of such issuance. For purposes of this subsection (iii),
the aggregate consideration receivable by the Company in connection with the
issuance of shares of Common Stock or of rights, warrants or other Convertible
Securities shall be deemed to be equal to the sum of the aggregate offering
price (before deduction of underwriting discounts or commissions and expenses
payable to third parties) of all such Common Stock, rights, warrants and
Convertible Securities plus the aggregate amount (as determined on the date of
issuance), if any, payable upon exercise or exercise of any such rights,
warrants and Convertible Securities into shares of Common Stock. If, subsequent
to the date of issuance of such right, warrants or other Convertible Securities,
the conversion or exercise price thereof is reduced, such aggregate amount shall
be recalculated and the Exercise Price and the number of shares of Common Stock
obtainable upon exercise of this Warrant shall be adjusted retroactively to give
effect to such reduction. On the expiration of any option or the termination of
any right to convert or exchange any securities into Additional Shares, the
Exercise Price then in effect hereunder shall forthwith be increased to the
Exercise Price which would have been in

                                       5
<PAGE>

effect at the time of such expiration or termination (but taking into account
other adjustments or potential made following the time of issuance of such
Options or securities) had such option or security, to the extent outstanding
immediately prior to such expiration or termination, never been issued and the
number of shares of Common Stock obtainable upon exercise of this Warrant shall
be correspondingly adjusted. If Common Stock is sold as a unit with other
securities, the aggregate consideration received for such Common Stock shall be
deemed to be net of the fair market value (as determined by the Board of
Directors in good faith) of such other securities. The issuance or reissuance of
(A) any shares of Common Stock or rights, warrants or other Convertible
Securities (whether treasury shares or newly issued shares) (1) pursuant to a
dividend or distribution on, or subdivision, combination or reclassification of,
the outstanding shares of Common Stock requiring an adjustment in the Exercise
Price pursuant to subsection (i) of this Section 2(a); (2) pursuant to any
restricted stock or stock option plan or program of the Company involving the
grant of Options or rights to acquire shares of Common Stock after the date
hereof to directors, officers and employees of the Company and its Subsidiaries;
(3) pursuant to any option, warrant, right, or Convertible Security outstanding
as of the Date of Issuance; (4) pursuant to any securities issued to a bank or
other similar financial institution solely in connection with the Senior Credit
Facility and the Senior Subordinated Credit Facility; or (5) pursuant to an
underwritten offering registered with the SEC if the offering price is greater
than the Exercise Price then in effect; (B) the Preferred Stock and any shares
of Common Stock issuable upon conversion or exercise thereof, or (C) the Series
1 Warrants and any shares of Common Stock issuable upon exercise thereof, shall
not be deemed to constitute an issuance of Common Stock or Convertible
Securities by the Company to which this subsection (iii) applies. No adjustment
shall be made pursuant to this subsection (iii) in connection with any
transaction to which SECTION 2(b) applies.

                  (iv) For purposes of this SECTION 2(a), the number of shares
of Common Stock at any time outstanding shall not include any shares of Common
Stock then owned or held by or for the account of the Company.

                  (v) All calculations of the Exercise Price pursuant to this
SECTION 2(a) shall be made to the nearest one one-hundredth of a cent. Anything
in this SECTION 2(a) to the contrary notwithstanding, (A) the Company shall not
be required to give effect to any adjustment in the Exercise Price unless and
until the net effect of one or more adjustments (each of which shall be carried
forward), determined as above provided, shall have resulted in a reduction of
the Exercise Price of at least 1%, and when the cumulative net effect of more
than one adjustment so determined shall be to reduce the Exercise Price by at
least 1%, such reduction in Exercise Price shall thereupon be given effect and
(B) in no event shall the then current Exercise Price be increased as a result
of any calculation made at any time pursuant to this SECTION 2(a).

                  (b) (i) In case of any capital reorganization or
reclassification of outstanding shares of Common Stock (other than a
reclassification to which SECTION 2(a)(i) shall apply), or in case of any merger
or consolidation of the Company with or into another Person (as defined below),
or in case of any sale or conveyance to another Person of all or substantially
all of the assets of the Company or any compulsory share exchange pursuant to
which share exchange the shares of Common Stock are converted into other
securities, cash or other property (each of the foregoing being referred to as a
"TRANSACTION"), this Warrant shall thereafter be exercisable for, in lieu of the
shares of Common Stock issuable upon such exercise prior to consummation of

                                       6
<PAGE>

such Transaction, the kind and amount of shares of stock and other securities
and property receivable (including cash) upon the consummation of such
Transaction by a holder of that number of shares of Common Stock into which the
Warrant was exercisable for immediately prior to such Transaction (including, on
a pro rata basis, the cash, securities or property received by holders of Common
Stock in any tender or exchange offer that is a step in such Transaction).

                  (ii) Notwithstanding anything contained herein to the
contrary, the Company will not effect any Transaction unless, prior to the
consummation thereof, (A) the Surviving Person shall agree that the Series 1
Warrants shall be treated as provided in paragraph (i) of this SECTION 2(b) and
the agreements governing such Transaction shall so provide and (B) the Surviving
Person thereof shall assume, by written instrument mailed, by first-class mail,
postage prepaid, to each holder of the Series 1 Warrants at such holder's
address as it appears in the records of the Company, the obligation to deliver
to such holder such cash or other securities to which, in accordance with the
foregoing provisions, such holder is entitled and such Surviving Person shall
have mailed, by first-class mail, postage prepaid, to each holder of the Series
1 Warrants at such holder's address as it appears in the records of the Company,
and an opinion of independent counsel for such Person stating that such
assumption agreement is a valid, binding and enforceable agreement of the
Surviving Person.

                  (c) In any case, if necessary, appropriate adjustment (as
determined in good faith by the Board of Directors) shall be made in the
application of the provisions set forth in this SECTION 2 with respect to rights
and interests thereafter of the holders of the Series 1 Warrants to the end that
the provisions set forth herein for the protection of the purchase rights of the
Series 1 Warrants shall thereafter be applicable, as nearly as reasonably may
be, to any such other shares of stock and other securities (other than the
Common Stock) and property deliverable upon exercise of the Series 1 Warrants
remaining outstanding with such adjustments in the Exercise Price and the number
of shares of Common Stock obtainable upon exercise of this Warrant and such
other adjustments in the provisions hereof as the Board of Directors shall in
good faith determine to be appropriate. In case securities or property other
than Common Stock shall be issuable or deliverable upon exercise as aforesaid,
then all references in this SECTION 2 shall be deemed to apply, so far as
appropriate and as nearly as may be, to such other securities or property.

                  (d) If the Company shall pay any dividend or make any other
distribution to the holders of its Common Stock (other than regularly quarterly
dividends payable in cash) or shall offer for subscription pro rata to the
holders of its Common Stock any additional shares of stock of any class or any
other right, or there shall be any Transaction, or there shall be a voluntary or
involuntary dissolution, liquidation or winding up of the Company, then, in any
one or more of said cases the Company shall give at least 15 days prior written
notice to the holders of the Series 1 Warrants by first-class mail, postage
prepaid, at their respective addresses as they shall appear in the records of
the Company of the earlier of the dates on which (i) the books of the Company
shall close or a record shall be taken for such stock dividend, distribution or
subscription rights or (ii) such Transaction, dissolution, liquidation or
winding up shall take place. Such notice shall also specify that date as of
which the holders of the Common Stock of record shall participate in said
dividend, distribution of subscription rights or shall be entitled to exchange
their Common Stock for securities or other property deliverable upon such
reorganization, reclassification, consolidation, merger, sale or conveyance or
participate in such dissolution, liquidation or

                                       7
<PAGE>

winding up, as the case may be. Failure to give such notice shall not invalidate
any action so taken.

                  Section 3. REPORTS AS TO ADJUSTMENTS. Upon the occurrence of
any event specified in SECTION 2(a) that would result in any adjustment of the
Exercise Price, then, and in each such case, the Company shall promptly deliver
by first-class mail, postage prepaid, at their respective addresses as they
shall appear in the records of the Company, a certificate signed by the
President or a Vice President and by the Treasurer or an Assistant Treasurer or
the Secretary or an Assistant Secretary of the Company setting forth in
reasonable detail the event requiring the adjustment and the method by which
such adjustment was calculated and specifying the Exercise Price then in effect
and the number of shares of Common Stock obtainable upon exercise of the Series
1 Warrants following such adjustment. Where appropriate, such notice to the
holders of the Series 1 Warrants may be given in advance and included as part of
the notice required pursuant to SECTION 2(d).

                  Section 4. DEFINITIONS. The following terms have meanings set
forth below:

                  "BUSINESS DAY" means any day other than a Saturday, Sunday, or
any day on which banks in New York City are authorized or obligated by
applicable law to close.

                  "COMMON STOCK" means, collectively, the Company's Common
Stock, par value $1 per share (including any associated Right, as defined in and
issued pursuant to the Rights Agreement, dated as of October 27, 1998, as
amended, by and between the Company and The Bank of New York (successor to First
Chicago Trust Company of New York), as Rights Agent.

                  "CONVERTIBLE SECURITIES" means any stock or securities
(directly or indirectly, after the passage of time or otherwise) convertible
into or exercisable or exchangeable for Common Stock.

                  "CURRENT MARKET PRICE," when used with reference to shares of
Common Stock or other securities on any date, shall mean the closing price per
share of Common Stock or such other securities on such date and, when used with
reference to shares of Common Stock or other securities for any period, shall
mean the average of the daily closing prices per share of Common Stock or such
other securities for such period. The closing price for each day shall be the
last sale price, regular way, or, in case no such sale takes place on such day,
the average of the closing bid and asked prices, regular way, in either case as
reported in the principal consolidated transaction reporting system with respect
to securities listed or admitted to trading on the New York Stock Exchange or,
if the Common Stock or such other securities are not listed or admitted to
trading on the New York Stock Exchange, as reported in the principal
consolidated transaction reporting system with respect to securities listed on
the principal national securities exchange on which the Common Stock or such
other securities are listed or admitted to trading or, if the Common Stock or
such other securities are not listed or admitted to trading on any national
securities exchange, the last quoted sale price or, if not so quoted, the
average of the high bid and low asked prices in the over-the-counter market, as
reported by the National Association of Securities Dealers, Inc. Automated
Quotation System or such other system then in use, or, if on any such date the
Common Stock or such other securities are not quoted by any such organization,
the average of the closing bid and asked prices as furnished by a professional

                                       8
<PAGE>

market maker making a market in the Common Stock or such other securities
selected by the Board of Directors of the Company. If the Common Stock or such
other securities are not publicly held or so listed or publicly traded, "CURRENT
MARKET PRICE" shall mean the fair market value per share of Common Stock or of
such other securities as determined by an independent investment banking firm
with an established national reputation as a valuer of equity securities
selected by the Company and reasonably acceptable to the holders of a majority
of the shares of Preferred Stock outstanding at the time.

                  "EXERCISE PRICE" shall mean $26.28.

                  "OPTIONS" means any rights, warrants or options to subscribe
for or purchase Common Stock or Convertible Securities.

                  "PERSON" or "PERSON" means any corporation, individual,
limited liability company, joint stock company, joint venture, partnership,
unincorporated association, governmental regulatory entity, country, state or
political subdivision thereof, trust, municipality or other entity.

                  "PURCHASE AGREEMENT" means the Preferred Stock and Warrant
Purchase Agreement, dated as of September 21, 2002, by and among the Company and
the investors listed in Schedule A thereto.

                  "SURVIVING PERSON" shall mean the continuing or surviving
Person of a merger, consolidation or other corporate combination, the Person
receiving a transfer of all or a substantial part of the properties and assets
of the Company, or the Person consolidating with or merging into the Company in
a merger, consolidation or other corporate combination in which the Company is
the continuing or surviving Person, but in connection with which the Preferred
Stock, Series 1 Warrants or Common Stock of the Company is exchanged or
converted into the securities of any other Person or the right to receive cash
or any other property.

                  "TRADING DAY" shall mean a day on which the principal national
securities exchange on which the Common Stock is listed or admitted to trading
is open for the transaction of business or, if the Common Stock is not listed or
admitted to trading on any national exchange, a Business Day.

                  Section 5. NO VOTING RIGHTS; LIMITATIONS OF LIABILITY. This
Warrant shall not entitle the holder hereof to any voting rights or other rights
as a stockholder of the Company. No provision hereof, in the absence of
affirmative action by the Registered Holder to purchase Common Stock, and no
enumeration herein of the rights or privileges of the Registered Holder shall
give rise to any liability of such holder for the Exercise Price of Common Stock
acquirable by exercise hereof or as a stockholder of the Company.

                  Section 6. WARRANT TRANSFERABLE. Subject to the transfer
conditions referred to in the legend endorsed hereon, including the provisions
of the Letter Agreement, this Warrant and all rights hereunder are transferable,
in whole or in part, without charge to the Registered Holder, upon surrender of
this Warrant with a properly executed Assignment (in the form of Exhibit I) at
the principal office of the Company.

                                       9
<PAGE>

                  Section 7. WARRANT EXCHANGEABLE FOR DIFFERENT DENOMINATIONS.
This Warrant is exchangeable, upon the surrender hereof by the Registered Holder
at the principal office of the Company, for new Series 1 Warrants of like tenor
representing in the aggregate the purchase rights hereunder, and each of such
new Series 1 Warrants shall represent such portion of such purchase rights as is
designated by the Registered Holder at the time of such surrender. The date the
Company initially issues this Warrant shall be deemed to be the "DATE OF
ISSUANCE" hereof regardless of the number of times new certificates representing
the unexpired and unexercised purchase rights formerly represented by this
Warrant shall be issued. All Series 1 Warrants representing portions of the
purchase rights hereunder are referred to herein as the "SERIES 1 WARRANTS."

                  Section 8. REPLACEMENT. Upon receipt of evidence reasonably
satisfactory to the Company (an affidavit of the Registered Holder shall be
satisfactory) of the ownership and the loss, theft, destruction or mutilation of
any certificate evidencing the Series 1 Warrants, and in the case of any such
loss, theft or destruction, upon receipt of indemnity reasonably satisfactory to
the Company (provided that if the holder is a financial institution or other
institutional investor its own agreement shall be satisfactory), or, in the case
of any such mutilation upon surrender of such certificate, the Company shall (at
its expense) execute and deliver in lieu of such certificate a new certificate
of like kind representing the number of Series 1 Warrants of such class
represented by such lost, stolen, destroyed or mutilated certificate and dated
the date of such lost, stolen, destroyed or mutilated certificate.

                  Section 9. NOTICES. Except as otherwise expressly provided
hereunder, all notices referred to herein shall be in writing and shall be
delivered by registered or certified mail, return receipt requested and postage
prepaid, or by reputable overnight courier service, charges prepaid, and shall
be deemed to have been given when so mailed or sent (i) to the Company, at its
principal executive offices, Attention: General Counsel and (ii) to any
Registered Holder, at such holder's address as it appears in the stock records
of the Company (unless otherwise indicated by any such holder).

                  Section 10. AMENDMENT AND WAIVER. Any provision of this
Warrant may be amended or modified in whole or in part at any time by an
agreement in writing among the Company and the holder of this Warrant. No
failure on the part of either the Company or the holder of this Warrant to
exercise, and no delay in exercising, any right shall operate as a waiver
thereof nor shall any single or partial exercise by either the Company or the
holder of this Warrant of any right preclude any other or future exercise
thereof or the exercise of any other right.

                  Section 11. DESCRIPTIVE HEADINGS; GOVERNING LAW. The
descriptive headings of the several Sections and paragraphs of this Warrant are
inserted for convenience only and do not constitute a part of this Warrant.
References in this Warrant to Sections and Exhibits are references to Sections
of, and Exhibits to, this Warrant unless otherwise noted. The corporation laws
of the State of Delaware shall govern all issues concerning the relative rights
of the Company and its stockholders. All other questions concerning the
construction, validity, enforcement and interpretation of this Warrant shall be
governed by the internal law of the State of Delaware, without giving effect to
any choice of law or conflict of law provision or rule

                                       10
<PAGE>

(whether of the State of Delaware or any other jurisdictions) that would cause
the application of the laws of any jurisdictions other than the State of
Delaware.

                  Section 12. SEVERABILITY. Should any part of this Warrant for
any reason be declared invalid, such decision shall not affect the validity of
the remaining portion, which remaining portion shall remain in full force and
effect as if this Warrant had been executed with the invalid portion thereof
eliminated, and it is hereby declared the intention of the Company hereto that
it would have executed the remaining portion of this Warrant without including
therein any such parts or parts which may, for any reason, be hereafter declared
invalid.

                  Section 13. ENTIRE AGREEMENT. This Warrant and the Letter
Agreement and the documents described herein and therein or attached or
delivered pursuant hereto or thereto set forth the entire agreement between the
Company and the Registered Holder with respect to the transactions contemplated
by this Warrant.

                                   * * * * * *

                                       11
<PAGE>

                  IN WITNESS WHEREOF, the Company has caused this Warrant to be
signed and attested by its duly authorized officers under its corporate seal and
to be dated the Date of Issuance hereof.

                                       R.H. DONNELLEY CORPORATION

                                       By:
                                          -------------------------------------
                                                           Name:
                                                           Title:

Attest:

------------------------------------
Name:
Title:

                                       12
<PAGE>

                                                                       EXHIBIT I

                                   ASSIGNMENT

                  FOR VALUE RECEIVED, ______________________________ hereby
sells, assigns and transfers all of the rights of the undersigned under the
attached Warrant (Certificate No. ____) with respect to the number of shares of
the Common Stock, par value $1 per share, of R.H. Donnelley Corporation, a
Delaware corporation, covered thereby set forth below, unto:

<TABLE>
<CAPTION>

Names of Assignee                             Address                           No. of Shares
-----------------                             -------                           -------------
<S>                                            <C>                                 <C>

</TABLE>

                                   Signature:
                                              ---------------------------------

                                   Address:
                                              ---------------------------------

                                   Witness:
                                              ---------------------------------

<PAGE>

                                                                      EXHIBIT II

                               EXERCISE AGREEMENT

To:  R.H. Donnelley Corporation                               Dated:

         The undersigned, pursuant to the provisions set forth in the attached
Warrant (Certificate No. ______), hereby agrees to subscribe for the purchase of
______ shares of the Common Stock, par value $1 per share (the "COMMON STOCK"),
of R.H. Donnelley Corporation, a Delaware corporation (the "COMPANY"), covered
by such Warrant and makes payment herewith in full therefor at the price per
share provided by such Warrant.

         The undersigned1 represents to the Company as follows:

                  (i) such Person (as defined in the Warrant) is an "accredited
         investor" within the meaning of Rule 501 of Regulation D promulgated
         under the Securities Act of 1933 (the "SECURITIES ACT") and was not
         organized for the specific purpose of acquiring the Common Stock
         issuable upon exercise thereof;

                  (ii) such person has sufficient knowledge, sophistication and
         experience in financial and business matters as are necessary to
         evaluate the risks and merits of an investment in the Company;

                  (iii) such Person has had an opportunity to discuss the
         Company's business, management and financial affairs with the Company's
         management;

                  (iv) the Common Stock being acquired by such Person is being
         acquired for its own account for the purpose of investment and not with
         a view to or for sale in connection with any distribution thereof; and

                  (v) such Person understands that (A) none of the shares of
         Common Stock issuable upon the exercise of the Warrant have been
         registered under the Securities Act and are being issued in reliance
         upon federal and state exemptions for transactions not involving any
         public offering, (B) the shares of Common Stock issuable upon the
         exercise of the Warrant must be held indefinitely unless a subsequent
         disposition thereof is registered under the Securities Act or is exempt
         from such registration, (C) the shares of Common Stock issuable upon
         the exercise of the Warrant will bear a legend to such effect, as
         applicable, and (D) the Company will make a notation on its transfer
         books to such effect.

                                                [NAME OF PERSON]

                                       By:
                                          -------------------------------------
                                          Name:
                                          Title:
                                          Address:

--------
1        In the event that the shares of Common Stock are not issued in the name
         of the Person (as defined in the Warrant) in whose name the Warrant is
         registered or if the number of shares of Common Stock to be issued does
         not include all of the shares purchasable under the Warrant, then this
         Exercise Agreement shall be modified to include applicable language
         with respect to the provisions of this Exercise Agreement

                                       14<PAGE>
                                                                    EXHIBIT 10.1
                                                                  EXECUTION COPY
                         GS Capital Partners 2000, L.P.
                     GS Capital Partners 2000 Offshore, L.P.
               GS Capital Partners 2000 Gmbh & Co. Beteiligungs KG
                  GS Capital Partners 2000 Employee Fund, L.P.
                 Goldman Sachs Direct Investment Fund 2000, L.P.
                            c/o Goldman, Sachs & Co.
                                 85 Broad Street
                            New York, New York 10004

                                                               November 25, 2002

R.H. Donnelley Corporation
R.H. Donnelley Inc.
One Manhattanville Road
Purchase, NY  10577

         Re: Investment in Preferred Stock of R.H. Donnelley Corporation

Ladies and Gentlemen:

        Reference is made to the Preferred Stock and Warrant Purchase Agreement,
dated as of September  21, 2002 (the  "Purchase  Agreement"),  by and among R.H.
Donnelley Corporation,  a Delaware corporation (the "Company") and the investors
listed in Schedule A thereto (the "Purchasers").  Capitalized terms used but not
otherwise  defined herein shall have the meanings  ascribed to such terms in the
Purchase Agreement.

        This will confirm our agreement as follows:

        1.      PURCHASE AND SALE.

                1.1.  The Company and the Purchasers hereby agree, subject to
the terms and conditions of this letter agreement, that the Company will sell to
the  Purchasers  and the  Purchasers  will  purchase from the Company (i) 70,000
shares of Series B-1 Preferred Stock (the "November Shares") created pursuant to
the Company's  Certificate of  Designations in the form of EXHIBIT A attached to
this letter agreement (the "B-1 Certificate of Designations")  and (ii) Warrants
to purchase  577,500 shares of Common Stock in  substantially  the form attached
hereto as EXHIBIT B (the "November  Warrants"),  for an aggregate purchase price
of  $70,000,000  (the  "Proceeds").  The Proceeds paid to the Company  hereunder
shall reduce, on a  dollar-for-dollar  basis, the cash component of the Purchase
Price  payable at the  Closing  Date for the  Preferred  Stock and the  Warrants
pursuant to the Purchase  Agreement.  Unless the November Shares are repurchased
by the Company  prior to the date the Sprint  Purchase  Agreement is  terminated
prior to the closing thereof,  the November Shares issued hereunder shall reduce
on a  share-for-share  basis  the  number  of  Preferred  Shares  to  which  the
Purchasers shall be entitled at the Closing, pursuant to the Purchase Agreement.
The November Warrants issued hereunder shall reduce on a  share-for-share  basis
the number of Warrants to which the Purchasers shall be entitled at the

<PAGE>
Closing  pursuant to the  Purchase  Agreement.  The closing of the  transactions
contemplated by this letter agreement (the "November  Closing") shall take place
on the date hereof  (the date of such  closing  being  referred to herein as the
"November  Closing  Date").  The  number of  November  Shares  and the number of
November  Warrants to be purchased by each Purchaser at the November Closing and
the portion of the Proceeds to be paid by each Purchaser at the November Closing
in exchange  therefor,  shall be as specified in SCHEDULE A hereto (with respect
to each such Purchaser, such Purchaser's "Specified Purchase Price").

                1.2. At the November Closing: (i) the Company will deliver to
the  Purchasers  certificates  for the November  Shares to be sold in accordance
with the provisions of SECTION 1.1 hereto registered in the respective names and
proportions set forth in SCHEDULE A hereto; (ii) the Company will deliver to the
Purchasers certificates for the November Warrants, to be sold in accordance with
the provisions of SECTION 1.1 hereto, in each case duly executed in favor of the
respective  names and in the proportions  set forth in SCHEDULE A hereto;  (iii)
subject to SECTION 6 hereof,  each  Purchaser,  in full payment for the November
Shares  and the  November  Warrants,  will  deliver to the  Company  immediately
available  funds, by wire transfer to such account as the Company shall specify,
such  Purchaser's  Specified  Purchase Price;  and (iv) each party shall take or
cause to happen such other  actions,  and shall  execute and deliver  such other
instruments or documents, as shall be required under SECTION 2 hereof.

        2.      CONDITIONS. The November Closing is subject to the following
conditions:

                2.1.  CONDITIONS OF PURCHASE.  The obligations of each Purchaser
to purchase  the  November  Shares and the  November  Warrants  at the  November
Closing  are  subject  to  satisfaction  or  waiver  of  each  of the  following
conditions on or prior to the November Closing Date.

                      (i) Each of the conditions contained in Sections 5.01(a),
                (b),  (c),  (d),  (e),  (g)(A),  (l)  and  (m) of  the  Purchase
                Agreement shall be satisfied on or prior to the November Closing
                as if set forth in their  entirety  herein and applicable to the
                transactions contemplated hereby. For further clarification, for
                purposes  hereof,  where  appropriate,  each  reference  in such
                sections  to "the  date of this  Agreement"  shall be  deemed to
                refer to the date of this letter  agreement,  each  reference to
                the  "Closing  Date"  shall be deemed to refer to the  "November
                Closing Date" and each  reference to "this  Agreement"  shall be
                deemed to refer to this letter agreement.

                      (ii) The B-1 Certificate of Designations shall have been
                duly filed with the  Secretary  of State of  Delaware  and shall
                have become effective and shall be in full force and effect;

                      (iii) All waivers and consents from third parties that the
                Purchasers   reasonably  believe  necessary  or  appropriate  in
                connection  with the  transactions  contemplated  by this letter
                agreement  shall have been  received  by the Company in form and
                substance reasonably  satisfactory to the Purchasers,  including
                without  limitation a written  confirmation  from JPMorgan Chase
                Bank under the Credit

<PAGE>
                Agreement,  dated as of June 5, 1998,  by and among the Company,
                R.H.   Donnelley,   Inc.,   The   Chase   Manhattan   Bank,   as
                Administrative  Agent and the Lenders party thereto,  as amended
                by the First Amendment to Credit Agreement, dated as of March 4,
                1999, by and among the Company,  R.H. Donnelley,  Inc. The Chase
                Manhattan Bank, as  Administrative  Agent, and the Lenders party
                thereto  (together,  the "Current Credit Agreement") in form and
                substance  reasonably  satisfactory  to the Purchasers  that the
                defaults  described in such  confirmation are not or will not be
                continuing as described and  conditioned  in such  confirmation;
                and

                      (iv) The Purchasers shall have received, dated the
                November  Closing  Date  and  addressed  to each  Purchaser,  an
                opinion of Jones,  Day, Reavis & Pogue,  counsel to the Company,
                substantially in the form attached as EXHIBIT C hereto;

                2.2. CONDITIONS OF SALE.  The  obligation of the Company to sell
the November Shares and the November Warrants at the November Closing is subject
to the satisfaction or waiver of each of the following conditions precedent:

                      (i) the conditions contained in Section 5.02(a), (b), (c),
                (d), and (e) of the Purchase  Agreement shall be satisfied on or
                prior to the November  Closing as if set forth in their entirety
                herein and applicable to the transactions  contemplated  hereby.
                For  further   clarification,   for   purposes   hereof,   where
                appropriate,  each  reference  in such  sections to "the date of
                this  Agreement"  shall be  deemed  to refer to the date of this
                letter agreement,  each reference to the "Closing Date" shall be
                deemed  to  refer  to  the  "November  Closing  Date"  and  each
                reference to "this  Agreement"  shall be deemed to refer to this
                letter agreement; and

                      (ii) the Purchasers shall have delivered immediately prior
                to or  concurrently  with the  November  Closing in  immediately
                available funds, by wire transfer to such account as the Company
                shall have  specified,  an amount  equal to the Proceeds to have
                been paid pursuant to Section 1 hereof.

        3.      AMENDMENTS TO PURCHASE AGREEMENT. The Purchase Agreement is
hereby amended as follows:

                3.1. If at the Closing the Company is required to issue an
additional amount of Preferred Shares to the Purchasers pursuant to Section 2.04
of the Purchase  Agreement,  the Company agrees that a similar  adjustment shall
also be made to the number of November  Shares and November  Warrants  issued to
the Purchasers  pursuant to this letter  agreement and to the Warrants issued to
the  Purchasers  pursuant  to the  Purchase  Agreement.  Section  2.04 is hereby
amended by adding "(other than the November  Shares and the November  Warrants)"
immediately before the words "(Common Stock Equivalents)" therein.

                3.2. Section 2.01 of the Purchase Agreement is hereby amended by
deleting  "$200.0  million" and by inserting  in its place  "$130.0  million or,
$200.0 million in the event the November Shares are redeemed pursuant to Section
5(a) of the B-1 Certificate of Designations

<PAGE>
by the Company  prior to the date the Sprint  Purchase  Agreement is  terminated
prior to the closing thereof".

                3.3. Solely for purposes of this letter agreement, the terms
"Indebtedness"  and "Leverage  Ratio" as used in Section  4.04(d) shall have the
meanings ascribed to such terms in the Current Credit Agreement.

                3.4. Section 4.02(b) of the Purchase Agreement is hereby amended
by deleting clause (vii) thereof.

                3.5. Section 4.04(e) of the Purchase  Agreement is hereby
amended by inserting at the end thereof:  "and other than any  transaction  that
requires the approval of the holders of the Company's common stock."

                3.6. Section 4.04(i) of the Purchase Agreement is hereby amended
by adding "and other than  dividends  from a wholly owned Company  Subsidiary to
its parent company" at the end of the first parenthetical thereof.

                3.7. Section 4.04(k) of the Purchase Agreement is hereby amended
by adding "or sell" after the word "issue" therein.

                3.8. The first sentence of Section 4.10(a) of the Purchase
Agreement is hereby amended by inserting "(i)" after the words "(any such act, a
"Transfer")  and by deleting the words  "except for," and inserting in its place
"or (ii) any November Shares or November Warrants prior to the first anniversary
of the November Closing Date, except in each case for,".

                3.9. The last sentence of Section 4.10(a) is hereby amended by
replacing it in its entirety with the following:  "The foregoing restrictions on
Transfer  shall cease to apply (i) in the case of any  Preferred  Shares  issued
upon the  exchange  of the  November  Shares,  and in the  case of any  November
Warrants,  from and after the first  anniversary  of the November  Closing Date,
(ii) in the case of any  other  Preferred  Shares  and  Warrants  issued  on the
Closing Date, from and after the first anniversary of the Closing Date and (iii)
upon the Trigger Date (as defined in the B-1  Certificate of  Designations),  so
long as, in each case,  such Transfer is made in compliance  with all applicable
requirements  of  law  and  any  necessary   governmental  approvals  have  been
obtained."

                3.10. The Company's reimbursement obligations pursuant to
Section 8.06(b)(ii) of the Purchase Agreement shall include the reasonable third
party and out-of-pocket expenses (including,  without limitation, all reasonable
fees and expenses of each  counsel,  accountants  and  consultants  of each such
party)  incurred by the  Purchasers or their  Affiliates in connection  with the
preparation,  negotiation, execution and performance of this letter agreement or
any of the transactions contemplated hereby.

<PAGE>

                3.11. Schedules 3.01(c), 3.01(d), 3.01(i)(i), 3.01(j) and 4.02
to the Purchase Agreement are amended by Schedules 3.01(c), 3.01(d), 3.01(i)(i),
3.01(j) and 4.02, respectively, to this letter agreement.

        4.      AMENDMENTS TO CERTIFICATE OF DESIGNATIONS, WARRANTS AND
REGISTRATION RIGHTS AGREEMENT.

                4.1. The Certificate of Designations governing the Preferred
Stock in the form of EXHIBIT A to the Purchase  Agreement  is hereby  amended by
deleting  EXHIBIT A to the Purchase  Agreement in its entirety and  replacing it
with the Certificate of Designations in the form attached as EXHIBIT D hereto.

                4.2. The certificate for the Warrants in the form attached as
EXHIBIT D to the Purchase  Agreement is herby  amended by deleting  EXHIBIT D to
the Purchase Agreement in its entirety and replacing it with the certificate for
the Warrants in the form attached as EXHIBIT E hereto.

                4.3. The Registration Rights Agreement in the form attached as
EXHIBIT C to the Purchase  Agreement is hereby amended by deleting  EXHIBIT C to
the Purchase  Agreement in its entirety and  replacing it with the  Registration
Rights Agreement in the form attached as EXHIBIT F hereto.

        5.      USE OF PROCEEDS.  The Company shall contribute the Proceeds to
R.H. Donnelley Inc.

        6.      CLOSING PAYMENT. On the November Closing Date, the Company
agrees to pay to each  Purchaser 1% of the portion of the Proceeds  paid by such
Purchaser to the Company on the November  Closing Date. Any obligations  owed by
the Company to the Purchasers pursuant to this Section 6 of the letter agreement
shall reduce on a  dollar-for-dollar  basis the amount payable to the Company by
the Purchasers pursuant to Section 1.1 hereof.

        7.      SUPPLEMENTAL INDENTURE. Immediately following the receipt by the
Company of the Proceeds,  the Company shall deliver to The Bank of New York (the
"Trustee") an executed copy of the  Supplemental  Indenture  (the  "Supplemental
Indenture") in the form attached as EXHIBIT G hereto.  The Company shall use its
best efforts to have the Trustee execute and deliver the Supplemental Indenture,
and any and all other  documents  required to make such  Supplemental  Indenture
effective,  to the Company,  with a copy to the  Purchasers,  promptly after the
receipt by the Company of the Proceeds.  If the Trustee has not delivered to the
Company and  Purchasers a fully executed copy of the  Supplemental  Indenture by
5:00 p.m.  New York time on November  27, 2002,  the  Purchasers  shall have the
right,  exercisable by written notice to the Company,  to require the Company to
promptly  repurchase  the  November  Shares  and the  November  Warrants  for an
aggregate price in cash equal to 101% of the Proceeds.

<PAGE>

        8.       CERTAIN RESTRICTED ACTIONS.

                 8.1. In addition to the restrictions set forth in Section 4.04
of the Purchase Agreement, from and after the November Closing Date, the Company
shall  not,  and shall  not  permit  any  Company  Subsidiary  to,  directly  or
indirectly,  take any of the following actions without the prior written consent
of  at  least  a  majority  of  the  then-outstanding  November  Shares  or  the
affirmative  vote in person or by proxy at a meeting  called for that purpose of
the holders of at least a majority of the November Shares voting thereat:

                 (i) dispose of or acquire any material assets for cash or
        equity; or

                 (ii) enter  into any  contract  which  requires  the  Company
        to make cash payments of more than $2 million in the aggregate; or

                  (iii) purchase any equity securities of the Company on the
        open market; or

                  (iv) except as disclosed on Schedule 8 to this letter
        agreement,  enter into, or amend in any material respect, any employment
        agreement  with, or other  compensation  to, any of the Chief  Executive
        Officer,  the Chief Financial  Offer, the General Counsel of the Company
        or the President of Donnelley Media; or

                  (v) amend or modify the DonTech Partnership Agreement or any
        related agreement in any material respect.

                 8.2. TERMINATION OF OBLIGATIONS. The obligations of the Company
set forth in Section 8.1 hereof shall  terminate  and no longer be of any effect
from and after the earlier to occur of (i) such time as the Purchasers no longer
hold any November  Shares or (ii) such time as the Purchasers no longer have the
right pursuant to the B-1 Certificate of Designations to elect a Director of the
Company.

        9.       APPLICABILITY  OF PURCHASE  AGREEMENT  PROVISIONS.  The partie
agree that the November  Closing is intended to be treated as an initial
closing under the Purchase  Agreement for purposes of the representations,
warranties, covenants, indemnities and agreements thereunder. In furtherance
thereof, the parties agree that:

                 9.1. All representations and warranties of the Company and the
Purchasers  made in Article III of the Purchase  Agreement shall be deemed to be
made on the date of this letter agreement and on the November Closing Date as if
set  forth  herein  in  their  entirety  and  applicable  to  the   transactions
contemplated thereby.

                 9.2. The Schedules to the Purchase Agreement (other than
Schedule A to the  Purchase  Agreement)  shall be deemed to be Schedules to this
letter  agreement and this letter  agreement  shall be deemed to be disclosed on
each  Schedule to the  Purchase  Agreement  where  disclosure  thereof  would be
appropriate.
<PAGE>

                 9.3. The provisions of Article VII of the Purchase Agreement
shall be applicable to the transactions contemplated by this letter agreement as
if set  forth  herein  in their  entirety  and  applicable  to the  transactions
contemplated hereby. In addition, the Company shall, from and after the November
Closing Date,  indemnify each of the Purchaser  Indemnified  Parties against and
hold them  harmless  from and against  all Losses  incurred by any of them based
upon,  resulting from or arising out of any actual or threatened claim,  action,
suit,   investigation  or  proceeding   ("Litigation")  against  such  Purchaser
Indemnified  Party  by any  Person  in  connection  with  (A)  the  transactions
contemplated by this letter agreement, (B) the negotiation,  execution, delivery
and  performance of this letter  agreement,  or any other document  contemplated
hereby, (C) any actions taken by any Purchaser Indemnified Party pursuant hereto
or in connection with the transactions  contemplated  hereby (whether or not the
transactions  contemplated hereby are consummated) or (D) the direct or indirect
ownership  by a Purchaser  Indemnified  Party of any  securities  of the Company
(including any Litigation to which a Purchaser  Indemnified  Party is made party
as a result thereof).

                 9.4. Except as set forth in this letter agreement, Sections
4.03,  4.04, 4.05, 4.08, 4.09, 4.10, 4.11, 4.13 and 4.15 (each as may be amended
hereby or from time to time) of the Purchase  Agreement shall be applicable from
and after the November Closing as if the November Closing were the Closing,  and
the November Shares shall be treated as if such shares are Preferred Shares.

                 10. AGREEMENT REGARDING DIVIDENDS. The Company agrees that on
and after January 31, 2003 it shall pay cash dividends on the November Shares on
a current  basis so long as it is not  precluded  from doing so under law or its
bank credit agreement or public indentures.  In furtherance thereof, the Company
shall (subject to the terms of its bank credit  agreement and public  indenture)
refrain from entering into any  agreements  which would  preclude such payments,
seek a waiver under any agreements which would prevent such payments at any time
and take whatever actions are necessary,  including  revaluing assets, to create
surplus for the purpose of paying such dividends.

                 11. DISCLOSURE. The Company shall not make any press release,
public  announcement  or filing  with any  Governmental  Entity  concerning  the
transactions  contemplated  by this letter  agreement or the Purchase  Agreement
unless mutually  agreed by the Company and the Purchasers,  except as and to the
extent that the Company shall be obligated to make any such  disclosure,  by law
or by the NYSE and then only after  consultation  with the Purchasers  regarding
the basis of such  obligation  and the  content  of such press  release,  public
announcement or filing.

                 12. ALLOCATIONS. The parties agree that, with respect to each
Purchaser,  the  portion  of the  Proceeds  payable  by each  Purchaser  will be
allocated: 90.0588% to the November Shares and 9.9413% to the November Warrants.
The parties  agree to report the sale and  purchase of the  November  Shares and
November  Warrants for all federal,  state,  local and foreign tax purposes in a
manner   consistent   with  this  allocation  and  agree  to  take  no  position
inconsistent  with  the  foregoing   (unless  otherwise   required  by  a  final
determination by the appropriate taxing authority).
<PAGE>

                 13. NO OTHER AMENDMENTS. Except as set forth in this letter
agreement,  all provisions of the Purchase  Agreement shall remain unchanged and
in full force and effect.

                 14. CERTAIN CONSENTS.

                     14.1. The Purchasers hereby consent, pursuant to Section
4.02(b) of the Purchase  Agreement,  to the  transactions  contemplated  by this
letter agreement.

                     14.2. Section 5(r) of the Purchase Agreement regarding the
Company's Senior Notes due 2010 and Senior Subordinated Notes due 2012 shall not
be amended or waived without the prior written consent of the Purchasers and the
Purchasers shall be third party beneficiaries of such Section.

                 15. MISCELLANEOUS.

                     15.1. This letter agreement shall be governed by, and
interpreted in accordance  with, the laws of the State of New York applicable to
contracts  made and to be performed in that State  without  giving effect to any
conflict of laws rules or principles  that might require the  application of the
laws of another jurisdiction.

                     15.2. The courts of the State of New York in New York
County and the United  States  District  Court for the Southern  District of New
York shall have  jurisdiction  over the parties  with  respect to any dispute or
controversy  between  them  arising  under or in  connection  with  this  letter
agreement and, by execution and delivery of this letter  agreement,  each of the
parties to this Agreement submits to the jurisdiction of those courts, including
but not limited to the IN  PERSONAM  and subject  matter  jurisdiction  of those
courts,  waives any objections to such  jurisdiction  on the grounds of venue or
FORUM NON CONVENIENS,  the absence of IN PERSONAM or subject matter jurisdiction
and any similar  grounds,  consents to service of process by mail (in accordance
with Section  15.4 of this letter  agreement)  or any other manner  permitted by
law,  and  irrevocably  agrees to be bound by any judgment  rendered  thereby in
connection with this Agreement.

                     15.3. All shares of capital stock held or acquired by each
of the  Goldman  Entities  shall  be  aggregated  together  for the  purpose  of
determining  the  availability  and  exercise of any right of each such  Goldman
Entity under this letter agreement.

                     15.4. All notices and other communications hereunder shall
be in made in the manner described in the Purchase Agreement.

                     15.5. No amendment, modification or alteration of the terms
or provisions of this letter  agreement  shall be binding on the parties  hereto
unless the same shall be in writing and duly  executed by such  parties,  except
that any of the terms or  provisions  of this letter  agreement may be waived in
writing at any time by the parties entitled to the benefits of such waived terms
or provisions. No waiver of any of the provisions of this letter agreement shall
be deemed to or shall constitute a waiver of any other provision hereof (whether
or not  similar).  No delay on the

<PAGE>

part of any party in exercising any right,  power or privilege  hereunder  shall
operate as a waiver  thereof.

                     15.6.  This letter  agreement  may be executed by facsimile
signature  and may be executed in one or more  counterparts,  each of which
shall be deemed to constitute an original, but all of which together shall
constitute but one agreement.

                     15.7. Nothing contained in this letter agreement or in any
instrument or document executed by any party in connection with the transactions
contemplated  hereby  shall  create  any  rights  in,  or be deemed to have been
executed  for the benefit of, any person that is not a party  hereto or thereto,
or, a successor or permitted assign of such a party.

<PAGE>
       Please confirm your agreement with the foregoing by signing and returning
one copy of this letter  agreement  to the  undersigned,  whereupon  this letter
agreement shall become a binding agreement between you and the Purchasers.

                             Very truly yours,

                             GS CAPITAL PARTNERS 2000, L.P.
                             By: GS Advisors 2000, L.L.C.
                                 Its General Partner

                             By: /s/ John E. Bowman
                                 ---------------------------------
                                 Name: John E. Bowman
                                 Its: Vice President

                             GS CAPITAL PARTNERS 2000 OFFSHORE, L.P.
                             By: GS Advisors 2000, L.L.C.
                                 Its General Partner

                             By: /s/ John E. Bowman
                                 ---------------------------------
                                 Name:  John E. Bowman
                                 Its:  Vice President

                             GS CAPITAL PARTNERS 2000 GmbH & CO.
                             BETEILIGUNGS KG

                             By: Goldman Sachs Management GP GmbH
                                 Its General Partner

                             By: /s/ John E. Bowman
                                 ---------------------------------
                                 Name:  John E. Bowman
                                 Its:  Managing Director

<PAGE>

                             GS CAPITAL PARTNERS 2000 EMPLOYEE FUND,
                             L.P.
                             By: GS Employee Funds 2000 GP, L.L.C.
                                 Its General Partner

                             By: /s/ John E. Bowman
                                 ---------------------------------
                                 Name:  John E. Bowman
                                 Its:  Vice President

                             GOLDMAN SACHS DIRECT INVESTMENT FUND
                             2000, L.P.
                             By: GS Employee Funds 2000 GP, L.L.C.
                                 Its General Partner

                             By: /s/ John E. Bowman
                                 ---------------------------------
                                 Name:  John E. Bowman
                                 Title:  Vice President

<PAGE>

Accepted and agreed as of
the date first written above:

R.H. DONNELLEY CORPORATION

By:     /s/ Robert J. Bush
    -----------------------------
    Name:  Robert J. Bush
    Title:  Vice President

R.H. DONNELLEY INC.

By:     /s/ Robert J. Bush
    -----------------------------
    Name:  Robert J. Bush
    Title:  Vice President

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00045-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00045-of-00352.parquet"}]]